AMPK Methods and Protocols

(Rick Simeone) #1

  1. CO 2 Incubator.
    Cell fixation

  2. 1PBS.

  3. Paraformaldehyde (PFA): 4% (w/v) PFA, 0.2% (w/v) Triton
    X-100.
    α-Actinin immunostaining

  4. Microscope slides.

  5. Dako pen for immunohistochemistry.

  6. PBS/BSA solutions: PBS, 1% (w/v) BSA and PBS, 0.1%
    (w/v) BSA.

  7. Mouse anti-α-actinin antibody (Sigma, A7811): for immunos-
    taining 1:750 in 1PBS, 1% (w/v) BSA.

  8. Alexa Fluor 594 donkey anti-mouse antibody (Invitrogen,
    A21203): for immunostaining 1:1000 in 1 PBS, 1%
    (w/v) BSA.

  9. Vectashield mounting medium with 1.5μg/ml of 4^0 ,6-Diami-
    dine-2^0 -phenylindole dihydrochloride (DAPI).

  10. Structured illumination fluorescent microscope.

  11. AxioVision 4.8 (or similar) software.


2.5 Evaluation
of NFAT
Transcriptional
Activity


Cell infection and treatment


  1. Cultured neonatal cardiomyocytes (700,000 cells per well).

  2. Full IMDM medium (as described in Subheading2.2,item 6).

  3. IMDM medium without serum (as described in Subheading
    2.2,item 7).

  4. NFAT/luciferase adenoviral construction: Ad5-NFAT-lucifer-
    ase reporter (Seven Hills Bioreagents, JMAd-10) [15]. Store at
     80 C(seeNote 5).
    5.β-Galactosidase adenoviral construction (used as control).
    Store at 80 C.

  5. PE, AICAr, and phenformin (as described in Subheading2.2,
    items 3– 5 ).
    Cell lysis

  6. Cell culture lysis 5reagent (CCLR, Promega, E1500). Dilute
    it in H 2 O to make 1lysis buffer.

  7. Cell scraper.

  8. 1PBS.
    NFAT-mediated luciferase activity measurement

  9. Luciferase assay buffer (Promega, E1500).


Study of Cardiac Hypertrophy and Protein Synthesis 327
Free download pdf